<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Ugekommentar #4 Helge Larsen om Genmab, Novo Nordisk m.m.]]></title><description><![CDATA[<p dir="auto">Ugekommentar #4 med redaktør på <a href="http://ProInvestor.com" rel="nofollow ugc">ProInvestor.com</a> Helge Larsen. Om tendenser og aktier, som debatteres på <a href="http://ProInvestor.com" rel="nofollow ugc">ProInvestor.com</a>. I denne uge tager han bl.a. fat i to populære emner - Genmab, hvor kursen har fået et skub opad, og Novo Nordisk, som opjusterer forventningerne.</p>
<p dir="auto"></p><div class="ratio ratio-16x9">
<iframe src="https://www.youtube-nocookie.com/embed/sptkqZ9dv3o" title="YouTube video player" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen"></iframe>
</div><p></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/442928/ugekommentar-4-helge-larsen-om-genmab-novo-nordisk-mm</link><generator>RSS for Node</generator><lastBuildDate>Sun, 05 Jul 2026 03:01:54 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/442928.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 05 Aug 2021 11:59:48 GMT</pubDate><ttl>60</ttl></channel></rss>